APOTEX, INC. v. CEPHALON, INC. et al

Filing 812

MEMORANDUM OPINION ORDER THAT DEFENDANTS' JOINT MOTION TO EXCLUDE TESTIMONY OF PLAINTIFF APOTEX, INC.'S FED. R. EVID. 701 WITNESS, GORDON FAHNER (DOC. NO. 683 ), IS GRANTED. SIGNED BY MAGISTRATE JUDGE DAVID R. STRAWBRIDGE ON 10/1/2014. 10/2/2014 ENTERED AND COPIES MAILED AND E-MAILED.(amas)

Download PDF
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA APOTEX, INC. v. CEPHALON, INC., et al. : : : : : CIVIL ACTION NO. 2:06-cv-2768 ORDER AND NOW this 1st day of October, 2014, for the reasons set forth in the attached Memorandum Opinion, it is hereby ORDERED that Defendants’ Joint Motion to Exclude Testimony of Plaintiff Apotex, Inc.’s Fed. R. Evid. 701 Witness, Gordon Fahner (Doc. 683), filed by Cephalon, Inc., Barr Laboratories, Inc., Mylan, Inc., Mylan Pharmaceuticals, Inc., Ranbaxy Laboratories, Ltd., Ranbaxy Pharmaceuticals, Inc., Teva Pharmaceutical Industries, Limited and Teva Pharmaceuticals USA, Inc. is GRANTED. BY THE COURT: /s/ David R. Strawbridge DAVID R. STRAWBRIDGE United States Magistrate Judge

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?